Parametric Portfolio Associates’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-18,619
Closed -$112K 4073
2019
Q4
$112K Buy
18,619
+206
+1% +$1.19K ﹤0.01% 3845
2019
Q3
$66K Buy
18,413
+3,147
+21% +$12.1K ﹤0.01% 3883
2019
Q2
$41K Sell
15,266
-5,748
-27% -$17K ﹤0.01% 3923
2019
Q1
$62K Buy
21,014
+3,700
+21% +$9.09K ﹤0.01% 3866
2018
Q4
$28K Sell
17,314
-7,159
-29% -$20.2K ﹤0.01% 3875
2018
Q3
$90K Sell
24,473
-4,224
-15% -$12.6K ﹤0.01% 3858
2018
Q2
$81K Sell
28,697
-4,503
-14% -$15.3K ﹤0.01% 3824
2018
Q1
$123K Sell
33,200
-22,029
-40% -$72.1K ﹤0.01% 3833
2017
Q4
$159K Sell
55,229
-16,697
-23% -$60.7K ﹤0.01% 3785
2017
Q3
$323K Sell
71,926
-62,230
-46% -$276K ﹤0.01% 3646
2017
Q2
$616K Buy
134,156
+30,893
+30% +$124K ﹤0.01% 3241
2017
Q1
$435K Buy
103,263
+77,748
+305% +$323K ﹤0.01% 3260
2016
Q4
$105K Sell
25,515
-7,239
-22% -$38.5K ﹤0.01% 3702
2016
Q3
$265K Sell
32,754
-33
-0.1% -$281 ﹤0.01% 3475
2016
Q2
$256K Buy
32,787
+937
+3% +$8.04K ﹤0.01% 3517
2016
Q1
$246K Sell
31,850
-15,202
-32% -$111K ﹤0.01% 3677
2015
Q4
$508K Buy
47,052
+3,535
+8% +$32.1K ﹤0.01% 3234
2015
Q3
$301K Sell
43,517
-25,130
-37% -$205K ﹤0.01% 2962
2015
Q2
$608K Buy
68,647
+23,343
+52% +$221K ﹤0.01% 3149
2015
Q1
$447K Sell
45,304
-524
-1% -$6.54K ﹤0.01% 3329
2014
Q4
$561K Sell
45,828
-16,081
-26% -$196K ﹤0.01% 3212
2014
Q3
$618K Buy
61,909
+7,791
+14% +$72.3K ﹤0.01% 3059
2014
Q2
$410K Buy
54,118
+42,497
+366% +$170K ﹤0.01% 3326
2014
Q1
$38K Buy
11,621
+495
+4% +$1.73K ﹤0.01% 3794
2013
Q4
$37K Buy
+11,126
New +$32.3K ﹤0.01% 3796
2013
Q3
Sell
-19,212
Closed -$157K 3840
2013
Q2
$157K Buy
+19,212
New +$147K ﹤0.01% 3530